kabutan

WAKAMOTO PHARMA, Returning to Profitability This Year

Thu May 15, 2025 4:00 pm JST Earnings

4512 WAKAMOTO PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

WAKAMOTO PHARMACEUTICAL CO.,LTD. <4512> [TSE Std] announced its financial results after the market closed on May 15th (16:00). The ordinary loss (non-consolidated) for the fiscal year ending March 2025 expanded to a loss of 409 million yen (compared to a loss of 161 million yen in the previous period). For the fiscal year ending March 2026, the ordinary profit/loss is expected to turn into a profit of 250 million yen.

In the most recent three-month period, from January to March (4Q), the ordinary profit/loss turned to a loss of 112 million yen (compared to a profit of 64 million yen in the same period last year). The operating profit/loss margin drastically worsened from 3.0% in the same period last year to -5.8%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 8,660 141 242 138 4.0 3 May 15, 2023 J-GAAP
Mar, 2024 7,738 -195 -161 108 3.1 3 May 15, 2024 J-GAAP
Mar, 2025 7,789 -457 -409 64 1.9 3 May 15, 2025 J-GAAP
YoY +0.7% -134.4% -154.0% -40.7% -40.9%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 7,780 -456 -407 50 1.4 3 Apr 25, 2025 J-GAAP
Mar, 2025 Results 7,789 -457 -409 64 1.9 3 May 15, 2025 J-GAAP
Revision Rate +0.1% -0.2% -0.5% +28.0% +28.5%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 3,811 -276 -256 -141 -4.1 0 Nov 6, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 15, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 7,738 -195 -161 108 3.1 3 May 15, 2024 J-GAAP
Mar, 2025 7,789 -457 -409 64 1.9 3 May 15, 2025 J-GAAP
Mar, 2026 Guidance 10,000 200 250 200 5.8 3 May 15, 2025 J-GAAP
YoY +28.4% － － +212.5% +211.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 2,152 64 64 313 9.1 3.0 May 15, 2024 J-GAAP
Apr - Jun, 2024 1,884 -89 -64 -11 -0.3 -4.7 Aug 2, 2024 J-GAAP
Jul - Sep, 2024 1,927 -187 -192 -130 -3.8 -9.7 Nov 6, 2024 J-GAAP
Oct - Dec, 2024 1,995 -65 -41 122 3.5 -3.3 Feb 5, 2025 J-GAAP
Jan - Mar, 2025 1,983 -116 -112 83 2.4 -5.8 May 15, 2025 J-GAAP
YoY -7.9% － － -73.5% -73.5%

Related Articles